169 related articles for article (PubMed ID: 37938837)
1. Clonal Hematopoiesis and Cardiovascular Disease in Patients With Multiple Myeloma Undergoing Hematopoietic Cell Transplant.
Rhee JW; Pillai R; He T; Bosworth A; Chen S; Atencio L; Oganesyan A; Peng K; Guzman T; Lukas K; Sigala B; Iukuridze A; Lindenfeld L; Jamal F; Natarajan P; Goldsmith S; Krishnan A; Rosenzweig M; Wong FL; Forman SJ; Armenian S
JAMA Cardiol; 2024 Jan; 9(1):16-24. PubMed ID: 37938837
[TBL] [Abstract][Full Text] [Related]
2. Coronary artery calcium and cardiovascular outcomes in patients with lymphoma undergoing autologous hematopoietic cell transplantation.
Wu S; Rhee JW; Iukuridze A; Bosworth A; Chen S; Atencio L; Manubolu V; Bhandari R; Jamal F; Mei M; Herrera A; Rodriguez F; Forman S; Nakamura R; Wong FL; Budoff M; Armenian SH
Cancer; 2024 Jun; 130(12):2205-2214. PubMed ID: 38358333
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations.
Calvillo-Argüelles O; Schoffel A; Capo-Chichi JM; Abdel-Qadir H; Schuh A; Carrillo-Estrada M; Liu S; Gupta V; Schimmer AD; Yee K; Shlush LI; Natarajan P; Thavendiranathan P
JACC CardioOncol; 2022 Mar; 4(1):38-49. PubMed ID: 35492819
[TBL] [Abstract][Full Text] [Related]
4. Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation.
Armenian SH; Sun CL; Mills G; Teh JB; Francisco L; Durand JB; Wong FL; Forman SJ; Bhatia S
Biol Blood Marrow Transplant; 2010 Aug; 16(8):1138-44. PubMed ID: 20197101
[TBL] [Abstract][Full Text] [Related]
5. Association of Diet Quality With Prevalence of Clonal Hematopoiesis and Adverse Cardiovascular Events.
Bhattacharya R; Zekavat SM; Uddin MM; Pirruccello J; Niroula A; Gibson C; Griffin GK; Libby P; Ebert BL; Bick A; Natarajan P
JAMA Cardiol; 2021 Sep; 6(9):1069-1077. PubMed ID: 34106216
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease.
Armenian SH; Sun CL; Vase T; Ness KK; Blum E; Francisco L; Venkataraman K; Samoa R; Wong FL; Forman SJ; Bhatia S
Blood; 2012 Nov; 120(23):4505-12. PubMed ID: 23034279
[TBL] [Abstract][Full Text] [Related]
7. Association between Clonal Hematopoiesis and Late Nonrelapse Mortality after Autologous Hematopoietic Cell Transplantation.
Slavin TP; Teh JB; Weitzel JN; Peng K; Wong FL; Qin H; Wang J; Wu X; Mei M; Pillai R; Wang Y; Tsang KK; Pozhitkov A; Krishnan A; Forman SJ; Armenian SH
Biol Blood Marrow Transplant; 2019 Dec; 25(12):2517-2521. PubMed ID: 31445185
[TBL] [Abstract][Full Text] [Related]
8. Acute kidney injury in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant: a cohort study.
Rodrigues N; Costa C; Branco C; Martins C; Lopes JA
J Nephrol; 2024 Mar; 37(2):419-428. PubMed ID: 38019417
[TBL] [Abstract][Full Text] [Related]
9. Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation.
Frick M; Chan W; Arends CM; Hablesreiter R; Halik A; Heuser M; Michonneau D; Blau O; Hoyer K; Christen F; Galan-Sousa J; Noerenberg D; Wais V; Stadler M; Yoshida K; Schetelig J; Schuler E; Thol F; Clappier E; Christopeit M; Ayuk F; Bornhäuser M; Blau IW; Ogawa S; Zemojtel T; Gerbitz A; Wagner EM; Spriewald BM; Schrezenmeier H; Kuchenbauer F; Kobbe G; Wiesneth M; Koldehoff M; Socié G; Kroeger N; Bullinger L; Thiede C; Damm F
J Clin Oncol; 2019 Feb; 37(5):375-385. PubMed ID: 30403573
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic training.
Scott JM; Armenian S; Giralt S; Moslehi J; Wang T; Jones LW
Crit Rev Oncol Hematol; 2016 Feb; 98():222-34. PubMed ID: 26643524
[TBL] [Abstract][Full Text] [Related]
11. Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Chang EK; Chanson D; Teh JB; Iukuridze A; Peng K; Forman SJ; Nakamura R; Wong FL; Cai L; Armenian SH
J Clin Oncol; 2021 Mar; 39(8):902-910. PubMed ID: 33417479
[TBL] [Abstract][Full Text] [Related]
12. Genetic Interleukin 6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis.
Bick AG; Pirruccello JP; Griffin GK; Gupta N; Gabriel S; Saleheen D; Libby P; Kathiresan S; Natarajan P
Circulation; 2020 Jan; 141(2):124-131. PubMed ID: 31707836
[TBL] [Abstract][Full Text] [Related]
13. Somatic and Germline Variants and Coronary Heart Disease in a Chinese Population.
Zhao K; Shen X; Liu H; Lin Z; Li J; Chen S; Liu F; Huang K; Cao J; Liu X; Shen C; Yu L; Zhao Y; Zhao L; Li Y; Hu D; Huang J; Lu X; Gu D
JAMA Cardiol; 2024 Mar; 9(3):233-242. PubMed ID: 38198131
[TBL] [Abstract][Full Text] [Related]
14. Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women.
Honigberg MC; Zekavat SM; Niroula A; Griffin GK; Bick AG; Pirruccello JP; Nakao T; Whitsel EA; Farland LV; Laurie C; Kooperberg C; Manson JE; Gabriel S; Libby P; Reiner AP; Ebert BL; ; Natarajan P
Circulation; 2021 Feb; 143(5):410-423. PubMed ID: 33161765
[TBL] [Abstract][Full Text] [Related]
15. Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease.
Akhiyat N; Lasho T; Ganji M; Toya T; Shi CX; Chen X; Braggio E; Ahmad A; Corban MT; Stewart K; Fernandez J; Xie Z; Finke C; Lerman LO; Patnaik MM; Lerman A
Arterioscler Thromb Vasc Biol; 2023 May; 43(5):774-783. PubMed ID: 36951061
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma.
Afrough A; Alsfeld LC; Milton DR; Delgado R; Popat UR; Nieto Y; Kebriaei P; Oran B; Saini N; Srour S; Hosing C; Cheema FH; Ahmed S; Manasanch EE; Lee HC; Kaufman GP; Patel KK; Weber DM; Orlowski RZ; Pinnix CC; Dabaja BS; Thomas SK; Champlin RE; Shpall EJ; Qazilbash MH; Bashir Q
Transplant Cell Ther; 2023 Apr; 29(4):264.e1-264.e9. PubMed ID: 35605883
[TBL] [Abstract][Full Text] [Related]
17. Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.
Gibson CJ; Lindsley RC; Tchekmedyian V; Mar BG; Shi J; Jaiswal S; Bosworth A; Francisco L; He J; Bansal A; Morgan EA; Lacasce AS; Freedman AS; Fisher DC; Jacobsen E; Armand P; Alyea EP; Koreth J; Ho V; Soiffer RJ; Antin JH; Ritz J; Nikiforow S; Forman SJ; Michor F; Neuberg D; Bhatia R; Bhatia S; Ebert BL
J Clin Oncol; 2017 May; 35(14):1598-1605. PubMed ID: 28068180
[TBL] [Abstract][Full Text] [Related]
18. Late cardiovascular complications after hematopoietic cell transplantation.
Chow EJ; Wong K; Lee SJ; Cushing-Haugen KL; Flowers ME; Friedman DL; Leisenring WM; Martin PJ; Mueller BA; Baker KS
Biol Blood Marrow Transplant; 2014 Jun; 20(6):794-800. PubMed ID: 24565992
[TBL] [Abstract][Full Text] [Related]
19. Primary Preventive Care of Hematopoietic Stem Cell Transplantation Survivors: Time to Educate and Empower Recipients and Providers.
Fulcher J; Blanchard AP; Bredeson C; van Walraven C
Transplant Cell Ther; 2023 Feb; 29(2):131.e1-131.e6. PubMed ID: 36336256
[TBL] [Abstract][Full Text] [Related]
20. Preexisting TP53-Variant Clonal Hematopoiesis and Risk of Secondary Myeloid Neoplasms in Patients With High-grade Ovarian Cancer Treated With Rucaparib.
Kwan TT; Oza AM; Tinker AV; Ray-Coquard I; Oaknin A; Aghajanian C; Lorusso D; Colombo N; Dean A; Weberpals J; Severson E; Vo LT; Goble S; Maloney L; Harding T; Kaufmann SH; Ledermann JA; Coleman RL; McNeish IA; Lin KK; Swisher EM
JAMA Oncol; 2021 Dec; 7(12):1772-1781. PubMed ID: 34647981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
